MARKET WIRE NEWS

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-03-11 14:52:39 ET

Achieve Life Sciences, Inc. (ACHV)

Q4 2024 Earnings Conference Call

March 11, 2025, 8:30 AM ET

Company Participants

Nicole Jones - IR

Richard Stewart - Chief Executive Officer

Cindy Jacobs - President and Chief Medical Officer

Jaime Xinos - Chief Commercial Officer

Mark Oki - Chief Financial Officer

Conference Call Participants

Gary Nachman - Raymond James

Thomas Flaten - Lake Street Capital Markets

Francois Brisebois - Oppenheimer and Company

Justin Walsh - Jones Trading

Brandon Folkes - Rodman & Renshaw

John Vandermosten - Zacks SCR

Boris Tolkachev - Freedom Broker

Presentation

Operator

Greetings, and welcome to the Achieve Life Sciences Fourth Quarter and Year-End 2024 Earnings Call and Webcast. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.

I would now like to turn the call over to your host Nicole Jones, Achieve Investor Relations. Thank you. You may begin.

Nicole Jones

Thank you, operator. Good morning, everyone, and thank you for joining us today. From Achieve Life Sciences, we are joined by Rick Stewart, Chief Executive Officer; Dr. Cindy Jacobs, President and Chief Medical Officer; Mark Oki, Chief Financial Officer; Jaime Xinos, Chief Commercial Officer; and Jerry Wan, Vice President of Finance and Principal Accounting Officer. Management will be available for a Q&A session following our prepared remarks.

As a reminder, a replay will be available later today by using the information provided in the earnings press release issued prior to this call or visiting the Achieve website.

Today's conference call will contain certain forward-looking statements including statements regarding the goals, strategies, beliefs, expectations and future potential operating results of Achieve. Although management believes these statements are reasonable based on estimates, assumptions and projections, as projections as of today, these statements are not guarantees of future performance.

Time sensitive information may no longer be accurate at the time of any telephonic or webcast replay. Actual results may differ materially as a result of risks, uncertainties and other factors, including, but not limited to the factors set forth in the company's filings with the SEC. Achieve undertakes no obligation to update or revise any of these forward-looking statements. Please refer to Achieve documents available on our website as and files with the SEC concerning factors that could affect the company....

Read the full article on Seeking Alpha

For further details see:

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript
Achieve Life Sciences Inc.

NASDAQ: ACHV

ACHV Trading

-4.6% G/L:

$5.16 Last:

204,434 Volume:

$5.30 Open:

COSM Ad 300

ACHV Latest News

ACHV Stock Data

$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App